Pharma Journalist -

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the…
Read More...

AbCellera and Kodiak Sciences Inc. announced a new partnership to generate therapeutic antibody candidates in ophthalmology. Following a previously successful collaboration, AbCellera…
Read More...

AbbVie announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients…
Read More...

Eli Lilly and Company announced an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555) 700 mg, an investigational neutralizing antibody, for…
Read More...

Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19…
Read More...

CStone Pharmaceuticals announced a licensing agreement with LegoChem Biosciences, Inc. for the development and commercialization of LCB71, a potential first-in-class/best-in-class…
Read More...

Releviate Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal…
Read More...

insitro, a machine-learning driven drug discovery and development company, today announced that it has entered into a five-year, discovery collaboration with Bristol Myers Squibb (NYSE:…
Read More...

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable…
Read More...

Apellis Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB (publ) announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan, a targeted C3 therapy,…
Read More...